(Q46696779)

24 December 2017

title

Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia (English)

1 reference

24 December 2017

1 reference

Mak RH

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

24 December 2017

The Journal of Pediatrics

published in

1 reference

24 December 2017

volume

129

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

97-104

1 reference

24 December 2017

Glucose and insulin metabolism in uremia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Lipid abnormalities in uremia, dialysis, and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on haemodialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

The influence of hyperparathyroidism on glucose metabolism in uremia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Role of parathyroid hormone in the glucose intolerance of chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Plasma amino acid levels in young subjects receiving diets containing 14 or 3.5 g nitrogen per day

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Serum proteins and plasma free amino acids in severe malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Plasma amino acids in children and adolescents on hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Hyperlipidemia in Children with Chronic Renal Insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Lipoproteins in children treated with continuous peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970195-6

10.1016/S0022-3476(96)70195-6

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017